Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCIS breast-conserving surgery trial of radiotherapy and tamoxifen
ACTRN12606000510549Phase 3Completed
- Sponsor
- Breast Cancer Trials
- Start
- Apr 1992
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of tamoxifen in breast cancer and ductal carcinoma in situ (DCIS) (4 arms), sponsored by Breast Cancer Trials. Primary endpoints: Disease-free survival and Overall survival. Started Apr 1992; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancerductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on ACTRN12606000510549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000510549.